Tackling ANTIBIOTIC RESISTANCE
Replace current antibiotic prophylaxis and therapy by natural antimicrobials that does not generate antibiotic resistance in 3 main nosocomial human pathogens: Acinetobacter Baumannii, Staphylococcus aureus, Pseudomonas aeruginosa
Biocidal (G+ & G-) and fungicidal on more than 250 pathogens
no perturbation on microflora in the GI tract of mammals (in vitro test on mices)
- IV and IP routes under preclinical tests (sepsis murine model with Acinetobacter baumannii)
- Improved efficiency of “soft niosome” versus lipid micelles or double micellar capsules
- Development of enteral route with better plasma profile than classical oral route